Letter raises concerns over compliance with FDA rules

12/7/2012 | Pharmalot.com

The FDA slapped Shanghai Huhui Daily Use Chemical Products with a warning letter for several violations, including redacting production records. These moves "raise serious concerns regarding the integrity, reliability and traceability of the data generated and documented in your batch production records," the FDA said in the letter.

View Full Article in:

Pharmalot.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC